These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3142595)

  • 1. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.
    Homburg R; Armar NA; Eshel A; Adams J; Jacobs HS
    BMJ; 1988 Oct; 297(6655):1024-6. PubMed ID: 3142595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.
    Homburg R; Eshel A; Armar NA; Tucker M; Mason PW; Adams J; Kilborn J; Sutherland IA; Jacobs HS
    BMJ; 1989 Mar; 298(6676):809-12. PubMed ID: 2496866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertility, megalocystic and polycystic ovaries: differential response to LHRH therapy.
    Tucker M; Adams J; Mason WP; Jacobs HS
    Ups J Med Sci; 1984; 89(1):43-6. PubMed ID: 6377641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation with pulsatile luteinising hormone releasing hormone.
    Mason P; Adams J; Morris DV; Tucker M; Price J; Voulgaris Z; Van der Spuy ZM; Sutherland I; Chambers GR; White S
    Br Med J (Clin Res Ed); 1984 Jan; 288(6412):181-5. PubMed ID: 6419847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of luteinizing hormone on fertility: fact or fantasy.
    Homburg R
    Baillieres Clin Obstet Gynaecol; 1998 Dec; 12(4):555-63. PubMed ID: 10627767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersecretion of luteinising hormone, infertility, and miscarriage.
    Regan L; Owen EJ; Jacobs HS
    Lancet; 1990 Nov; 336(8724):1141-4. PubMed ID: 1978024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
    Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
    Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.
    Adams J; Franks S; Polson DW; Mason HD; Abdulwahid N; Tucker M; Morris DV; Price J; Jacobs HS
    Lancet; 1985 Dec 21-28; 2(8469-70):1375-9. PubMed ID: 2867389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is changing hypothalamic activity important for control of ovulation?
    Clayton RN; Royston JP; Chapman J; Wilson M; Obhrai M; Sawers RS; Lynch SS
    Br Med J (Clin Res Ed); 1987 Jul; 295(6589):7-12. PubMed ID: 3113619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
    Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome.
    Eshel A; Abdulwahid NA; Armar NA; Adams JM; Jacobs HS
    Fertil Steril; 1988 Jun; 49(6):956-60. PubMed ID: 3286291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and follicular phase estradiol are better predictors of pregnancy outcome than luteinizing hormone in menotropin ovulation induction for anovulatory polycystic ovarian syndrome.
    McClure N; McDonald J; Kovacs GT; Healy DL; McCloud PI; McQuinn B; Burger HG
    Fertil Steril; 1993 Apr; 59(4):729-33. PubMed ID: 8458487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: comparisons in patients with normal or elevated luteinizing hormone.
    Abu-Heija AT; Fleming R; Yates RW; Coutts JR
    Hum Reprod; 1995 Dec; 10(12):3317-9. PubMed ID: 8822466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.